Fallon Wellness Pharmacy Recalls Hydroxocobalamin Injections Due to Sterility Concerns
Fallon Wellness Pharmacy is recalling 70 vials of Hydroxocobalamin injections in New York due to a lack of assurance of sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall involves a risk-of-harm product (injection) where injury has not yet been reported, fitting the High severity criteria.
Plain-English summary
Fallon Wellness Pharmacy, L.L.C. is recalling 70 vials of Hydroxocobalamin injections in three concentrations: 1000mcg/mL, 5mg/0.5mL, and 5000mcg/0.2mL. The recall is being conducted because of a lack of assurance of sterility.
The affected products were distributed in New York. The specific lot numbers involved are 02092015@59 (Exp 4/10/15), 02122015@49 (Exp 4/13/15), 02132015@44 (Exp 4/14/15), and 02192015@34 (Exp 4/20/15).
Consumers and healthcare providers should stop using these products and contact the recalling firm or their healthcare provider for further instructions.
The recalled product
- Product
- Hydroxocobalamin 1) 1000mcg/mL, 2) 5mg/0.5mL, 3) 5000mcg/0.2mL injection, Fallon Wellness Pharmacy, L.L.C., Latham, NY 12110
- Manufacturer
- Fallon Wellness Pharmacy, L.L.C.
- Category
- Drug — Injection
- Hazard
- Affected units
- 70
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- Lot#: a) 02092015@59
- Exp 4/10/15
- b) 02122015@49
- Exp 4/13/15
- c) 02132015@44
- Exp 4/14/15
- d) 02192015@34
- Exp 4/20/15
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 10 recalled by Fallon Wellness Pharmacy, L.L.C. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 10 products in this recall →Related recalls
Same manufacturer · Fallon Wellness Pharmacy, L.L.C.
See all →- SevereFallon Wellness Pharmacy Recalls Papaverine Injection Due to Sterility Concerns
FDA (Drugs) · 2016-12-14
- SevereFallon Wellness Pharmacy Recalls PAPA/PHEN/PROST Injection Due to Sterility Concerns
FDA (Drugs) · 2016-12-14
- SevereFallon Wellness Pharmacy Recalls Prostaglandin Rx Injections Due to Sterility Concerns
FDA (Drugs) · 2015-05-20
- SevereFallon Wellness Pharmacy Recalls Methylcobalamin/B-Complex Injection Due to Sterility Concerns
FDA (Drugs) · 2015-05-20
- SevereFallon Wellness Pharmacy Recalls Methylcobolamin Injections Due to Sterility Concerns
FDA (Drugs) · 2015-05-20
Same hazard · sterility
See all →- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereGreen Valley Drugs Recalls Hydroxocobalamin Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- HighDowning Labs Recalls Hydroxocobalamin Injection Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- SevereRXQ Compounding Recalls Hydroxocobalamin Injections Due to Sterility Concerns
FDA (Drugs) · 2019-08-14
- SevereBedford Pharmacy Recalls Hydroxocobalamin Injection Due to Sterility Concerns
FDA (Drugs) · 2015-10-21
- SevereHydroxocobalamin Injectable Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2014-01-22
- SevereHydroxocobalamin Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2021-11-17